PT1507519E - Medicamento com libertacao retardada da substancia activa, contendo 1-dimetilamino-3-(3-metoxifenil)-2-metilpentan-3-ol - Google Patents

Medicamento com libertacao retardada da substancia activa, contendo 1-dimetilamino-3-(3-metoxifenil)-2-metilpentan-3-ol

Info

Publication number
PT1507519E
PT1507519E PT03732464T PT03732464T PT1507519E PT 1507519 E PT1507519 E PT 1507519E PT 03732464 T PT03732464 T PT 03732464T PT 03732464 T PT03732464 T PT 03732464T PT 1507519 E PT1507519 E PT 1507519E
Authority
PT
Portugal
Prior art keywords
methylpentan
methoxyphenyl
medication
dimethylamino
active substance
Prior art date
Application number
PT03732464T
Other languages
English (en)
Portuguese (pt)
Inventor
Bartholomaeus Johannes
Iris Ziegler
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of PT1507519E publication Critical patent/PT1507519E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT03732464T 2002-05-29 2003-05-26 Medicamento com libertacao retardada da substancia activa, contendo 1-dimetilamino-3-(3-metoxifenil)-2-metilpentan-3-ol PT1507519E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10224108A DE10224108A1 (de) 2002-05-29 2002-05-29 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol enthaltendes Arzneimiitel mit verzögerter Wirkstofffreisetzung

Publications (1)

Publication Number Publication Date
PT1507519E true PT1507519E (pt) 2006-08-31

Family

ID=29557413

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03732464T PT1507519E (pt) 2002-05-29 2003-05-26 Medicamento com libertacao retardada da substancia activa, contendo 1-dimetilamino-3-(3-metoxifenil)-2-metilpentan-3-ol

Country Status (14)

Country Link
EP (1) EP1507519B1 (enExample)
JP (1) JP5459818B2 (enExample)
AR (1) AR039900A1 (enExample)
AT (1) ATE326218T1 (enExample)
AU (1) AU2003238397A1 (enExample)
CA (1) CA2488220C (enExample)
DE (2) DE10224108A1 (enExample)
DK (1) DK1507519T3 (enExample)
ES (1) ES2263976T3 (enExample)
MY (1) MY134311A (enExample)
PE (1) PE20040529A1 (enExample)
PL (1) PL218397B1 (enExample)
PT (1) PT1507519E (enExample)
WO (1) WO2003099267A1 (enExample)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
US5582837A (en) * 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
JPH06172161A (ja) * 1992-12-10 1994-06-21 Shin Etsu Chem Co Ltd 徐放性錠剤
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
JPH1017497A (ja) * 1996-07-02 1998-01-20 Takeda Chem Ind Ltd 徐放性製剤およびその製造方法
DE10059412A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
DE50303372D1 (de) 2006-06-22
EP1507519A1 (de) 2005-02-23
CA2488220A1 (en) 2003-12-04
JP5459818B2 (ja) 2014-04-02
DK1507519T3 (da) 2006-08-28
AR039900A1 (es) 2005-03-09
ATE326218T1 (de) 2006-06-15
WO2003099267A1 (de) 2003-12-04
PE20040529A1 (es) 2004-08-24
CA2488220C (en) 2011-02-01
EP1507519B1 (de) 2006-05-17
JP2005534640A (ja) 2005-11-17
AU2003238397A1 (en) 2003-12-12
MY134311A (en) 2007-12-31
PL218397B1 (pl) 2014-11-28
DE10224108A1 (de) 2004-01-29
PL374186A1 (en) 2005-10-03
ES2263976T3 (es) 2006-12-16

Similar Documents

Publication Publication Date Title
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
DE60316552D1 (de) Tablette mit hohem wirkstoffgehalt
DE60321386D1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
PT1207867E (pt) Formas de administracao farmaceuticas orais retardadas contendo tramadol
ATE380544T1 (de) Umhüllte feste darreichungsform
DE60331153D1 (de) Reboxetin enthaltende tablette mit verzögerter wirkstoffabgabe
EP1477403A4 (en) MEDICINES SUPPLY
NO2012017I1 (no) Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen.
NO20053041D0 (no) Behandling av diabetes.
NO20053150D0 (no) System for administrasjon av medisin.
PL363215A1 (pl) Kompozycja farmaceutyczna o zmniejszonej tendencji do krystalizacji leku
NO20054555D0 (no) Farmasoytiske preparater som omfatter syrestabilisert insulin
NO20031273D0 (no) Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
IS7571A (is) Ný lífeðlisfræðilega virk efni
PT1154777E (pt) Medicamento para o tratamento de hipertensao arterial
NL1028193A1 (nl) Farmaceutisch werkzame verbindingen.
DE60225686D1 (de) Paracetamol enthaltende tablette
DK1494650T3 (da) Farmaceutisk formulering, der indeholder melatonin
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
RU2002107079A (ru) Вещество, обладающее седативным действием
DE60306379D1 (de) Diffusionskontrolliertes wirkstoffabgabesystem mit fluorosiloxan-matrix
DK1474152T3 (da) Orodispergerbar farmaceutisk sammensætning omfattende ivabradin
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
DE60136367D1 (de) Pharmazeutische zusammensetzung mit modifiziertem träger
PT1507519E (pt) Medicamento com libertacao retardada da substancia activa, contendo 1-dimetilamino-3-(3-metoxifenil)-2-metilpentan-3-ol